Does weekly paclitaxel provide clinical benefit in patients with unresectable angiosarcoma?
Weekly paclitaxel demonstrates clinical benefit and is well tolerated in unresectable angiosarcoma.
Weekly paclitaxel at the dose schedule used in the current study was well tolerated and demonstrated clinical benefit.
Penel et al. (2008) studied this question.